Effect of a novel hypoglycemic agent, KAD-1229 on glucose metabolism and fructose-2,6-bisphosphate content in isolated hepatocytes of normal rats

Diabetes Research and Clinical Practice

Volumn 34, Issue 1, 1996, Pages 13-22

  Nakashima, Eitaro ^a   Nakamura, Jiro ^a   Koh, Naoki ^a   Sakakibara, Fumihiko ^a   Hamada, Yoji ^a   Hotta, Nigishi ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

6 phosphofructo 2 kinase; fructose 2,6 bisphosphatase; gluconeogenesis; glycolysis; sulfonylurea

Indexed keywords

ANTIDIABETIC AGENT; FRUCTOSE 2,6 BISPHOSPHATE; MITIGLINIDE; SUCCINIC ACID DERIVATIVE; TOLBUTAMIDE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; GLUCONEOGENESIS; GLUCOSE METABOLISM; LIVER CELL; MALE; NONHUMAN; RAT;

ANALYSIS OF VARIANCE; ANIMALS; CELLS, CULTURED; FRUCTOSEDIPHOSPHATES; GLUCONEOGENESIS; GLUCOSE; GLYCOLYSIS; HYPOGLYCEMIC AGENTS; INDOLES; KINETICS; LACTATES; LIVER; MALE; PYRUVATES; RATS; RATS, WISTAR; TOLBUTAMIDE;

EID: 0030249555     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8227(96)01331-9     Document Type: Article

References (42)

1. [1] Rajan, A.S., Aguilar, B.L., Nelson, D.A., et al. (1990) Ion channels and insulin secretion. Diabetes Care 13, 340-363.
2. [2] Barnes, A.J., Crowley, M., Garbien, K. and Bloom, A. (1974) Effect of short and long term chlorpropamide treatment on insulin release and blood glucose. Lancet 2, 69-72.
3. [3] Feldman, J.M. and Levobitz, H.E. (1971) Endocrine and metabolic effects of glibenclamide: evidence for an extra-pancreatic mechanism of action. Diabetes 20, 745-755.
4. [4] DeFronzo, R.A. and Simonson, D.C. (1984) Oral sulfonylurea agents suppress hepatic glucose production in non-insulin-dependent diabetic individuals. Diabetes Care 1, 72-80.
5. [5] Kolterman, O.G., Gray, R.S., Shapiro, G., Scarlett, J.A., Griffin, J. and Olefsky, J.M. (1984) The acute and chronic effects of sulfonylurea therapy in type II diabetic subjects. Diabetes 33, 346-354.
6. [6] Zawadski, J., Wolfe, R., Mott, D., Lillioja, B., Howard, B. and Bogardus, C. (1988) Increased rate of Cori cycle in obese subjects with NIDDM and effects of weight reduction. Diabetes 37, 154-159.
7. [7] Consoli, A., Nurjhan, N., Reilly, J.J., Bier, D.M. and Gerich, J.E. (1990) Mechanism of increased gluconeogenesis in noninsulin-dependent diabetes mellitus. Role of alterations in systemic, hepatic, and muscle lactate and alanine metabolism. J. Clin. Invest. 86, 2038-2045.
8. [8] McGuinness, O.P., Green, D.R. and Cherrington, A.D. (1987) Glyburide sensitizes perfused rat liver to insulin-induced suppression of glucose output. Diabetes 36, 472-476.
9. [9] Fleig, W.E., Noether, F.G., Fussgaenger, R. and Ditschuneit, H. (1984) Modulation by a sulfonylurea of insulin-dependent glycogenesis, but not of insulin binding, in cultured rat hepatocytes. Evidence for a postreceptor mechanism of action. Diabetes 33, 285-290.
10. [10] Pilkis, S.J., El-Maghrabi, M.R. and Claus, T.H. (1990) Fructose-2,6-bisphosphate in control of hepatic gluconeogenesis. From metabolites to molecular genetics. Diabetes Care 13, 582-99.
11. [11] Van Schaftingen, E. (1993) Glycolysis revisited. Diabetologia 36, 581-588.
12. [12] Monge, L., Mojena, M., Ortega, J.L., Samper, B., Cabello, M.A. and Feliu, J.E. (1986) Chlorpropamide raises fructose-2,6-bisphosphate concentration and inhibits gluconeogenesis in isolated rat hepatocytes. Diabetes 35, 89-96.
13. [13] Matsutani, A., Kaku, K. and Kaneko, T. (1984) Tolbutamide stimulates fructose-2, 6-bisphosphate formation in perfused rat liver. Diabetes 33, 495-498.
14. [14] Ohnota, H., Koizumi, T., Tsutsumi, N., Kobayashi, M., Inoue, S. and Sato, F. (1994) Novel rapid-and short-acting hypoglycemic agent, a calcium(2s)-2-benzyl-3-(cis-hexahydro-2-isoindolinylcarbonyl) propionate (KAD-1229) that acts on the sulfonylurea receptor: comparison of effects between KAD-1229 and gliclazide. J. Pharmacol. Exp. Ther. 269, 489-495.
15. [15] Ohnota, H., Koizumi, T., Kobayashi, M., Momose, Y. and Sato, F. (1995) Normalization of impaired glucose tolerance by the short-acting hypoglycemic agent calcium (2s)-2-benzyl-3-(cis-hexahydro-2-isoindolinylcarbonyl) propionate (KAD-1229) in non-insulin-dependent diabetes mellitus rats. Can. J. Physiol. Pharmacol. 73, 1-6.
16. [16] Berry, M.N. and Friend, D.S. (1969) High-yield preparation of isolated rat liver parenchymal cells. J. Cell. Biol. 43, 506-520.
17. [17] Hotta, N., Komori, T., Kobayashi, M., Sakakibara, F., Koh, N. and Sakamoto, N. (1993) The inhibitory action of buformin, a biguanide on gluconeogenesis from alanine and its transport system in rat livers. Diabetes Res. Clin. Pract. 19, 49-58.
18. [18] Felíu, J.E., Mojena, M., Correas, I. and Marco, J. (1982) Lack of effect of bovine pancreatic polypeptide on glucose production by isolated rat hepatocytes. Diabete. Metab. 2, 141-145.
19. [19] Claus, T.H., Plikis, S.J. and Park, C.R. (1975) Stimulation by glucagon of the incorporation of U-14C-labeled substrates into glucose by isolated rat hepatocytes. Biochim. Biophys. Acta 404, 110-123.
20. [20] Felíu, J.E., Hue, L. and Hers, H.C. (1976) Hormonal control of pyruvate kinase activity and of gluconeogenesis in isolated rat hepatocytes. Proc. Natl. Acad. Sci, USA 73, 829-837.
21. [21] Hohorst, H.J. (1965) L-(+)-Lactate determination with lactic dehydrogenase and DPN. In: H. Bergmeyer (Ed.), Methods of Enzymatic Analysis, Academic Press, New York, pp. 266-270.
22. [22] Hohorst, H.J. (1965) D-glucose 6-phosphate and D-fructose 6-phosphate. Determination with glucose 6-phosphate dehydrogenase and phosphoglucose isomerase. In: H. Bergmeyer (Ed.). Methods of Enzymatic Analysis, Academic Press, Orlando, FL, pp. 134-138.
23. [23] Van Schaftingen, E., Lederer, B., Bartrons, R. and Hers, H.G. (1982) A kinetic study of pyrophosphate: fructose-6-phosphate phosphotransferase from potato tubers. Application to a microassay of fructose 2,6-bisphosphate. Eur. J. Biochem. 129, 191-195.
24. [24] Gliemann, J. (1965) Insulin-like activity of dilute human serum assayed by an isolated adipose cell method. Diabetes 14, 643-649.
25. [25] Bartrons, R., Hue, L., Van Schaftingen, E. and Hers, H.G. (1983) Hormonal control of fructose-2,6-bisphosphate concentration in isolated rat hepatocytes. Biochem. J. 214, 829-837.
26. [26] Van Schaftingen, E., Davies, D.R. and Hers, H.G. (1982) Fructose-2,6-bisphosphatase from rat liver. Eur. J. Biochem. 124, 143-149.
27. [27] López-Alarcón, L., Muñoz-Alonso, M.J., Guijarro, C. and Feliu, J.E. (1995) Modulation of glycogen phosphorylase activity and fructose 2,6-bisphosphate levels by glibenclamide and meglitinide in isolated rat hepatocytes: a comparative study. Metabolism 44, 1000-1007.
28. [28] Monge, L., Cabello, M.A., Samper, B., Mojena, M. and Feliu, J.E. (1988) Tolbutamide enhances insulin action on gluconeogenesis and on fructose 2,6-bisphosphate levels in isolated rat hepatocytes. Diabete. Metab. 14, 712-716.
29. [29] Cabello, M.A., Monge, L., Ortega, J.L., Samper, B. and Feliu, J.E. (1987) Effect of glipizide on hepatic fructose 2,6-bisphosphate concentration and glucose metabolism. Metabolism 36, 738-742.
30. [30] Cabello, M.A., Rodriguez, T.G., Ortega, J.L., Samper, B. and Felíu, J.E. (1991) Inhibition of gluconeogenesis by tolbutamide in isolated rat hepatocytes: modulation of glucose-6-phosphate substrate cycle. Metabolism 40, 934-940.
31. [31] Hers, H.G. and Van, S.E. (1982) Fructose 2,6-bisphosphate 2 years after its discovery. Biochem. J. 206, 1-12.
32. [32] Hers, H.G. and Hue, L. (1983) Gluconeogenesis and related aspects of glycolysis. Annu. Rev. Biochem. 52, 617-653.
33. [33] Neely, P., El, M.M., Pilkis, S.J. and Claus, T.H. (1981) Effect of diabetes, insulin, starvation, and refeeding on the level of rat hepatic fructose 2,6-bisphosphate. Diabetes 30, 1062-1064.
34. [34] El, M.M., Claus, T.H., Pilkis, J. and Pilkis, S.J. (1982) Regulation of 6-phosphofructo-2-kinase activity by cyclic AMP-dependent phosphorylation. Proc. Natl. Acad. Sci. USA 79, 315-319.
35. [35] Sakakibara, R., Kitajima, S. and Uyeda, K. (1983) Differences in kinetic properties of phospho and dephospho forms of fructose-6-phosphate, 2-kinase and fructose 2,6-bisphosphatase. J. Biol. Chem. 259, 41-46.
36. [36] Ayame, H., Matsutani, A., Inoue, H., Kaneko, T. and Kaku, K. (1995) Tolbutamide inhibits glucagon-induced phosphorylation of 6PF-2-K/Fru-2,6-P2ase in rat hepatocytes. Am. J. Physiol. 268, E391-E396.
37. [37] López-Alarcón, L., Berbil-Bautista, P.R., Guijarro, C. and Felíu, J.E. (1988) Glipentide and glucose metabolism in isolated rat hepatocytes. Biochem. Pharmcol. 37, 3177-3182.
38. 2, chemistry and biological function. Mol. Cell. Biochem. 48, 97-120.
39. [39] Pilkis, S.J., El, M.M., McGrane, M., Pilkis, J., Fox, E. and Claus, T.H. (1982) Fructose 2,6-bisphosphate: a mediator of hormone action at the fructose 6-phosphate/ fructose 1,6-bisphosphate substrate cycle. Mol. Cell. Endocrinol. 25, 245-266.
40. [40] Hue, E., Blackmore, P.F. and Exton, J.H. (1981) Fructose 2,6-bisphosphate. Hormonal regulation and mechanism of its formation in liver. J. Biol. Chem. 256, 8900-8903.
41. [41] Mannaerts, G., Debeer, L. and DeSchepper, P.J. (1974) Metabolic effects of hypoglycemic sulfonylureas-III, Effect of chlorpropamide on energy metabolism and ketogenesis in the isolated perfused rat liver. Biochem. Pharmacol. 23, 75-87.
42. [42] Patel, T.B. (1986) Effects of tolbutamide on gluconeogenesis and glycolysis in isolated perfused rat liver. Am. J. Physiol. 250, E82-E86.